Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 2,322 | 4,016 | -153,473 | 74,150 | 34,727 |
| Operating Income | -2,322 | -4,016 | 153,473 | -74,150 | -34,727 |
| Other Income | 4,404 | -2,155 | 10,639 | -43,868 | 8,485 |
| Pre-tax Income | 2,082 | -6,171 | 164,112 | -118,018 | -26,242 |
| Net Income Continuous | 2,082 | -6,171 | 164,112 | -118,018 | -26,242 |
| Net Income | $2,082 | $-6,171 | $164,112 | $-118,018 | $-26,242 |
| EPS Basic Total Ops | 12.85 | -11.24 | 304.00 | -227.87 | -97.93 |
| EPS Basic Continuous Ops | 12.95 | -11.24 | 303.91 | -227.83 | -98.37 |
| EPS Diluted Total Ops | 8.04 | -11.24 | 304.00 | -227.87 | -97.93 |
| EPS Diluted Continuous Ops | 8.09 | -11.24 | 303.91 | -227.83 | -98.37 |
| EPS Diluted Before Non-Recurring Items | 3.75 | -11.51 | -11.51 | -20.14 | N/A |
| EBITDA(a) | $-2,299 | $-3,991 | $153,497 | $-74,125 | $-34,703 |